Shah M.A., Udrea A.A., Bondarenko I., Mansoor W., Sánchez R.G., Sarosiek T., Bozzarelli S., Schenker M., Gomez-Martin C., Morgan C., Özgüroğlu M., Pikiel J., Kalofonos H.P., Wojcik E., Buchler T., Swinson D., Cicin I., Joseph M., Vynnychenko I., Luft A.V., Enzinger P.C., Salek T., Papandreou C., Tournigand C., Maiello E., Wei R., Ferry D., Gao L., Oliveira J.M., Ajani J.A. (2022)
Studies JVDB and JVCZ examined alternative ramucirumab dosing regimens as monotherapy or combined with paclitaxel, respectively, in patients with advanced/metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma. ...